Abstracts Archive - Page 2318 of 2425 - ACR Meeting Abstracts

Abstract Number: 1571 • 2012 ACR/ARHP Annual Meeting
Pain and Fatigue in Adult Patients with Rheumatoid Arthritis – Associations with Demographic Factors, Disease Related Factors, Body Awareness, Emotional and Psychosocial Factors
Helena Lööf¹, Fredrik Saboonchi², Elisabet Welin Henriksson³, Staffan Lindblad⁴ and Unn-Britt Johansson⁵, ¹Sophiahemmet University College, Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden, ²Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Medicine, Stockholm, Sweden, ³Karolinska Institutet, Department of Neurobiology, Care Sciences and Society., Stockholm, Sweden, ⁴Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden, ⁵Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden

Background/Purpose: Patient´s with Rheumatoid arthritis highlight fatigue as a major concern, as well as pain as a priority for improvement. Previous study has found that…
Abstract Number: 1572 • 2012 ACR/ARHP Annual Meeting
Developing a Health Literacy Universal Precautions Toolkit for Rheumatology
Leigh F. Callahan¹, Victoria Hawk², Kimberly A. Broucksou², Betsy Hackney³, Deb MacDonald⁴, Lindsay Penny Prizer⁵, Beth L. Jonas⁶, Thomas K. Bauer⁷, Rima E. Rudd⁸, Cindy Brach⁹ and Darren Dewalt², ¹Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC, ²Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, ³Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴Thurston Arthritis Research Center, University of North Carolina Chapel Hill, Chapel Hill, NC, ⁵Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, ⁶Thurston Arthritis Research Ct, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁷Novant Health, Winston Salem, NC, ⁸Department of Society, Human Development, and Health, Harvard School of Public Health, Boston, MA, ⁹Agency for Health Care Research and Quality, Agency for Health Care Research and Quality, Rockville, MD
Background/Purpose: Research supports that health disparities exist between those with limited versus adequate literacy skills. Limited health literacy is associated with medication errors, increased healthcare…
Abstract Number: 1573 • 2012 ACR/ARHP Annual Meeting
Baseline Screening Recommendations for Rheumatoid Arthritis Patients Treated with Disease Modifying Anti-Rheumatic Drugs: Does an Educational Intervention Change Practice in an Outpatient Clinic?
Debra C. Lloyd¹, John N. Mecchella² and Daniel Albert³, ¹Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, ²Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ³Rheumatology, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine, Lebanon, NH
Background/Purpose: In 2008, the American College of Rheumatology (ACR) developed recommendations for use of non-biologic and biologic DMARDs in the treatment of rheumatoid arthritis (RA). …
Abstract Number: 1574 • 2012 ACR/ARHP Annual Meeting
The Correlation of Disease Activity, Functional Status and Quality of Life with Sleep Disturbance and Balance Status in Ankylosing Spondylitis (AS)
Mehmet Tuncay Duruoz¹, Zuhre Sari Surmeli¹ and Esra Topcu², ¹PMR Department, Rheumatology Division, Celal Bayar University Medical School, Manisa, Turkey, ²PMR Department, Celal Bayar University Medical School, Manisa, Turkey
Background/Purpose: To assess the correlation of disease activity, functional and metrological status and quality of life with sleep quality and balance status in AS. Methods:…
Abstract Number: 1575 • 2012 ACR/ARHP Annual Meeting
The Impact of Targeted Exercise Intervention On Health Outcomes in Rheumatoid Arthritis
Laura J. Durcan¹, Fiona Wilson², Finbar (Barry) D. O'Shea³ and Gaye Cunnane⁴, ¹Rheumatology, Mater Misercordiae University Hospital, Dublin 7, Ireland, ²Physiotherapy, Trinity College Dublin, Dublin, Ireland, ³Rheumatology Dept, St James's Hospital, Dublin, Ireland, ⁴Dept of Rheumatology, St James's Hospital, Dublin, Ireland
Background/Purpose: Increased morbidity and mortality are recognized consequences of rheumatoid arthritis (RA). In addition to chronic inflammation, reduced physical activity may contribute to adverse outcomes…
Abstract Number: 1576 • 2012 ACR/ARHP Annual Meeting
Identifying Subgroups of Rheumatoid Arthritis Patients Based On Levels of Pain, Disability, and Depression
Taylor Draper¹, Sarah R. Ormseth², M. Custodio³, Michael H. Weisman⁴, M.R. Irwin⁵ and Perry M. Nicassio⁵, ¹Psychology, Loma Linda University, Loma Linda, CA, ²Cousins Center for PNI, University of California, Los Angeles, Los Angeles, CA, ³UCLA, Los Angeles, CA, ⁴Cedars-Sinai Medical Center, Los Angeles, CA, ⁵Cousins Center for PNI, UCLA, Los Angeles, CA
Background/Purpose: Pain, disability, and depression are present in various degrees in patients with Rheumatoid Arthritis (RA). In spite of meeting the same diagnostic criteria, some…
Abstract Number: 1537 • 2012 ACR/ARHP Annual Meeting
Pathogenesis of Atherosclerosis in Granulomatosis Polyangiitis
Rula Hajj-Ali¹, Roy L. Silverstein², Gary S. Hoffman³ and Carol A. Langford⁴, ¹Cleveland Clinic Foundation, Cleveland, OH, ²Blood Research Institute, Medical College of Wisconsin, Milwaukee, WI, ³Rheumatic & Immunologic Dis, Cleveland Clinic Found A50, Cleveland, OH, ⁴Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH
Background/Purpose: Previous studies from our group suggested that the inflammatory events that occur during relapses in patients with Granulomatosis with Polyangiitis (GPA, Wegener’s) may have…
Abstract Number: 1538 • 2012 ACR/ARHP Annual Meeting
ANCA-Associated Vasculitis in Hispanic Americans: An Unrecognized Severity
Ranadeep Mandhadi¹, Fadi Aldaghlawi², Asad Khan², Vajiha Irshad³, Joel A. Block² and Antoine Sreih⁴, ¹Mount Sinai Hospital, Chicago, IL, ²Rush University Medical Center, Chicago, IL, ³Internal Medicine, Stroger Hospital of Cook County, Chicago, IL, ⁴Medicine/Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: ANCA-associated vasculitis, once a disease thought to predominate in Caucasians, is now increasingly recognized in diverse ethnic populations. However, there has been little systematic…
Abstract Number: 1539 • 2012 ACR/ARHP Annual Meeting
Microscopic Polyangiitis: A Large Single Center Series
Leslie D. Wilke¹, Guy P. Fiocco² and Marilyn Prince-Fiocco³, ¹Division of Pulmonary, Critical Care and Sleep Medicine, Scott & White Memorial Center, Temple, TX, ²Division of Rheumatology, Scott & White Clinic, Temple, TX, ³Temple, TX
Background/Purpose: Microscopic polyangiitis (MPA) is a rare systemic, ANCA (anti-neutrophil cytoplasmic antibody)-associated vasculitis of unclear etiology, characterized by necrotizing small vessel involvement with few or…
Abstract Number: 1540 • 2012 ACR/ARHP Annual Meeting
Practice Patterns in the Treatment of ANCA-Associated Vasculitis: Exploring Differences Among Subspecialties At a Single Academic Medical Center
Lindsy J. Forbess¹, Kenneth W. Griffin² and Robert F. Spiera³, ¹Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Public Health, Weill Cornell Medical College, New York, NY, ³Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Randomized controlled trial evidence helps guide physician treatment choices for ANCA-Associated Vasculitis (AAV). Data for remission maintenance therapy following rituximab (RTX) in generalized disease,…
Abstract Number: 1541 • 2012 ACR/ARHP Annual Meeting
Does Leflunomide Have a Place As Remission Maintenance Therapy in ANCA-Associated Vasculitis? A Bayesian Network Meta-Analysis with Hypothesis Driven Sensitivity Analyses to Adjust for Potential Biases
Glen S. Hazlewood¹, Claudia Metzler², George A. Tomlinson³, Wolfgang L. Gross⁴, Brian M. Feldman⁵, Loic Guillevin⁶ and Christian Pagnoux⁷, ¹Medicine, University of Toronto, Toronto, ON, Canada, ²University of Lubeck, Bad Branstedy, Germany, ³University of Toronto, Toronto, ON, Canada, ⁴Dept of Clinical Rheumatology, Medical University at Lubeck, Lubeck, Germany, ⁵Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ⁶Internal Medicine, Cochin University Hospital, Paris, France, ⁷Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada
Background/Purpose: Primary: To determine the relative treatment effects of maintenance therapy in adult patients with ANCA-associated vasculitis who have achieved remission, using a Bayesian network…
Abstract Number: 1542 • 2012 ACR/ARHP Annual Meeting
The Efficacy of Rituximab Vs Cyclophosphamide for Treatment of Renal Disease in ANCA-Associated Vasculitis: The RAVE Trial Geetha D, Fervenza FC for the RAVE-Itn Research Group
Duvuru Geetha¹ and Fernando Fervenza², ¹Nephrology, Johns Hopkins University, Baltimore, MD, ²Mayo Clinic, Rochester, MN
Background/Purpose: Rituximab (RTX) is non-inferior to cyclophosphamide (CYC) followed by azathioprine (AZA) for remission-induction in severe ANCA associated vasculitis (AAV) but details of outcomes among…
Abstract Number: 1543 • 2012 ACR/ARHP Annual Meeting
Rituximab for ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Trials
Carolina Mejia¹ and Carlos J. Lozada², ¹Internal Medicine, Mount Sinai Medical Center, Miami, FL, ²Dept of Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL
Background/Purpose: Over the past 40 years, cyclophosphamide/glucocorticoids combination therapy has been the standard regimen for remission induction in ANCA-associated vasculitis.. Although a major advance in…
Abstract Number: 1544 • 2012 ACR/ARHP Annual Meeting
Long-Term Outcome of Patients with Granulomatosis with Polyangiitis (Wegener’s) Treated with Rituximab
Lama Azar¹, Jason Springer², Meng Xu³, Tiffany M. Clark⁴, Carol A. Langford⁵ and Gary S. Hoffman⁴, ¹Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, ²Dept of Rheumatology, Cleveland Clinic Foundation, Cleveland, OH, ³Section of biostatistics, Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, ⁴Rheumatic & Immunologic Dis, Cleveland Clinic Foundation, Cleveland, OH, ⁵Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH
Background/Purpose: Rituximab (RTX) is an efficacious alternative to cyclophosphamide for treatment of granulomatosis with polyangiitis (GPA). However, relapses have been observed, long-term efficacy is not…
Abstract Number: 1545 • 2012 ACR/ARHP Annual Meeting
Long-Term Follow-up of 118 Polyarteritis Nodosa and Microscopic Polyangiitis without Poor-Prognosis Factors
Maxime Samson¹, Xavier Puechal², Hervé Devilliers³, Camillo Ribi⁴, Pascal Cohen⁵, Boris Bienvenu⁶, Christian Pagnoux⁷, Luc Mouthon⁸, Loic Guillevin⁹ and French Vasculitis Study Group FVSG¹⁰, ¹Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France; Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France, ²Internal Medicine, Hôpital Cochin, Paris, France, ³Internal medicine, Hôpital Général, Dijon, France, ⁴Internal Medicine, Hôpital Universitaire Cantonal de Genève, Geneve, Switzerland, ⁵National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, ⁶Division of Internal Medicine, Centre Hospitalier Régional Universitaire de Caen, Côte de Nacre, Caen, France, Caen, France, ⁷Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada, ⁸Internal Medicine, Hopital Cochim, Paris, France, ⁹Internal Medicine, Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, ¹⁰Internal Medicine, Service de médecine interne, Centre de Références des Vascularites, Université Paris Descartes, APHP, Hôpital Cochin, 75005 Paris, France., Paris, France
Background/Purpose: Polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA) are 2 vasculitides characterized by necrotizing inflammation of the vessel wall. They share several clinical features and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].